A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : irAEs

Search Conditions:
Search Keyword : irAEs
Search Method : Exact match.
Research Area:

Abbreviation: irAEs
Appearance Frequency: 787 time(s)
Long forms: 10

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
immune-related adverse events
(761 times)
(310 times)
ICIs (188 times)
PD-1 (85 times)
CTLA-4 (78 times)
1995 Pretreatment regimens for adverse events related to infusion of amphotericin B.
immune-related AEs
(15 times)
(12 times)
AEs (10 times)
AE (4 times)
PD-1 (3 times)
2012 Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
Immunotherapy-related adverse events
(4 times)
(1 time)
CITE (1 time)
FDA (1 time)
ICIs (1 time)
2016 Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports.
ICIs are associated with unique immune mediated adverse events
(1 time)
(1 time)
ICIs (1 time)
2019 A case of checkpoint inhibitor-induced celiac disease.
immune response adverse events
(1 time)
Drug Therapy
(1 time)
CAR (1 time)
NSCLC (1 time)
2016 Immunotherapy to Treat Cancer.
immune-related adverse
(1 time)
(1 time)
ICIs (1 time)
2018 Association of immune-related adverse (irAEs) with immune-checkpoint inhibitors (ICIs) efficacy in solid tumors.
immune-related phenomena and adverse events
(1 time)
(1 time)
ASCO (1 time)
2010 Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management.
inflammatory responses
(1 time)
Allergy and Immunology
(1 time)
PBMCs (1 time)
2020 The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade.
inhibitors related adverse effects
(1 time)
(1 time)
ICIs (1 time)
2019 [The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors].
10  ipilimumab causes a variety of autoimmune-related adverse events
(1 time)
ACTH (1 time)
CSF (1 time)
WBC (1 time)
2019 Relapse of aseptic meningitis induced by ipilimumab and nivolumab therapy for metastatic renal cell carcinoma: A case report.